i am comparing the ability to kill covid surrogate (and thus efficacy/effectiveness to reduce risk of transmission) to something that actually does reduce risk of transmission (disinfectant).
this phone case will not reduce risk of transmission. simple. it does not reduce the viral load enough.
- Forums
- ASX - By Stock
- NVU
- Ann: Nanoveu Validates Antiviral Technology Against Coronaviruses
Ann: Nanoveu Validates Antiviral Technology Against Coronaviruses, page-22
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NVU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
-0.002(4.65%) |
Mkt cap ! $20.70M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 3.9¢ | $65.40K | 1.651M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2852 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 93077 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2852 | 0.040 |
4 | 101300 | 0.038 |
4 | 200867 | 0.037 |
5 | 661100 | 0.036 |
3 | 153000 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 93077 | 1 |
0.042 | 50000 | 1 |
0.043 | 245702 | 3 |
0.044 | 209593 | 1 |
0.045 | 580000 | 2 |
Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
Featured News
NVU (ASX) Chart |